Healthcare provider profile · identity verified

Marcos Lima Lopez, MD

Internal Medicine · NORTH MIAMI BEACH, FL · NPI 1629429808

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	540	202
Metformin Hcl	Metformin Hcl	482	176
Amlodipine Besylate	Amlodipine Besylate	356	125
Losartan Potassium	Losartan Potassium	287	101
Lisinopril	Lisinopril	264	96
Rosuvastatin Calcium	Rosuvastatin Calcium	253	103
Alendronate Sodium	Alendronate Sodium	227	86
Tamsulosin Hcl	Tamsulosin Hcl	224	81
Diclofenac Sodium	Diclofenac Sodium	197	122
Glipizide	Glipizide	197	66
Gabapentin	Gabapentin	181	81
Hydrochlorothiazide	Hydrochlorothiazide	170	57
Fluticasone Propionate	Fluticasone Propionate	145	62
Levothyroxine Sodium	Levothyroxine Sodium	126	38
Trazodone Hcl	Trazodone Hcl	116	53
Donepezil Hcl	Donepezil Hcl	109	41
Simvastatin	Simvastatin	106	38
Albuterol Sulfate Hfa	Albuterol Sulfate	97	39
Metoprolol Tartrate	Metoprolol Tartrate	97	37
Nifedipine Er	Nifedipine	97	37
Omeprazole	Omeprazole	97	50
Metoprolol Succinate	Metoprolol Succinate	87	30
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	78	28
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	76	25
Furosemide	Furosemide	74	33
Carvedilol	Carvedilol	71	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	71	16
Sildenafil Citrate	Sildenafil Citrate	70	23
Triamcinolone Acetonide	Triamcinolone Acetonide	70	44
Pantoprazole Sodium	Pantoprazole Sodium	66	40
Clopidogrel	Clopidogrel Bisulfate	55	21
Memantine Hcl	Memantine Hcl	50	18
Eliquis	Apixaban	47	22
Finasteride	Finasteride	46	14
Oxybutynin Chloride	Oxybutynin Chloride	45	18
Allopurinol	Allopurinol	44	16
Atenolol	Atenolol	43	14
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	43	suppressed
Azithromycin	Azithromycin	41	36
Tizanidine Hcl	Tizanidine Hcl	38	22
Novolog Flexpen	Insulin Aspart	37	suppressed
Ketoconazole	Ketoconazole	34	23
Meclizine Hcl	Meclizine Hcl	33	26
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	29	suppressed
Ibuprofen	Ibuprofen	29	20
Alprazolam	Alprazolam	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	24
Montelukast Sodium	Montelukast Sodium	24	suppressed
Tadalafil	Tadalafil	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	21
Famotidine	Famotidine	23	17
Januvia	Sitagliptin Phosphate	23	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	23	23
Jardiance	Empagliflozin	22	suppressed
Prednisone	Prednisone	22	11
Tramadol Hcl	Tramadol Hcl	22	suppressed
Spironolactone	Spironolactone	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	12
Ondansetron Odt	Ondansetron	20	15
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Meloxicam	Meloxicam	17	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	14
Nitroglycerin	Nitroglycerin	17	suppressed
Ozempic	Semaglutide	17	suppressed
Sertraline Hcl	Sertraline Hcl	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Novolog	Insulin Aspart	15	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Lovastatin	Lovastatin	14	suppressed
Temazepam	Temazepam	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error